Wendy Guy - 28 Jul 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role: Chief Administrative Officer
Signature: /s/ Wendy Guy by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol: PCSA
Transactions as of: 28 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 28 Jul 2025, 16:36:46 UTC
Previous filing: 18 Sep 2025
Next filing: 03 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Guy Wendy	Chief Administrative Officer	C/O PROCESSA PHARMACEUTICALS, INC., 601 21ST STREET SUITE 300, VERO BEACH	/s/ Wendy Guy by Michael B. Kirwan, as Attorney-in-Fact	28 Jul 2025	0001799360

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCSA	Restricted Stock Units	Award	$0	+1,366,046	+13095%	$0.000000	1,376,478	24 Jul 2025	Common Stock	1,366,046	$0.000000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,349,245 shares are subject to stockholder approval of the revised Omnibus Plan.
F2	Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.